vimarsana.com

Page 33 - ஒன்றுபட்டது கிஂக்டம் அலுவலகம் க்கு தேசிய புள்ளிவிவரங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mass testing shouldn t be part of the UK s plan to return to normality

Coronavirus testing has been a central part of many countries’ response to the pandemic. The UK government in particular has been prepared to spend up to £100 billion on testing (although this plan has since been abandoned) and recently announced plans to enable all citizens to perform up to two rapid tests per week. Coronavirus tests can help to prevent the virus spreading by identifying infected people and their contacts, who can be asked – or told – to isolate. This means a positive test result can have severe effects, potentially closing schools or businesses and causing whole families or groups to go into legally enforced isolation.

How Covid gave the world a lesson in tackling air pollution

By Katrina Krämer2021-04-15T08:30:00+01:00 ‘A 7% drop – we’ve never seen this since world war two,’ says Corinne Le Quéré, professor of climate change science at the University of East Anglia, UK. Le Quéré is talking about an unprecedented global decrease in carbon emissions in modern times, the result of the coronavirus pandemic. 1 The data Le Quéré and other atmospheric scientists have gathered over the last year are both shocking and insightful. They show a world that was profoundly altered by a virus that has killed more than 2.5 million people to date, while giving a glimpse of what a future with cleaner air might look like – one that could save many lives.

More than half of UK has Covid-19 antibodies

More than half of UK has Covid-19 antibodies On 14 April 2021, the UK Office for National Statistics (ONS) issued a report that suggests 54% of the UK population had antibodies to Covid-19 by 28 March 2021. The comparable percentage in Switzerland could be around 25%, however there is no up to date data to indicate this. © motortion | Dreamstime.com Most of the antibodies detected in the UK are likely to be the result of vaccination. By 3 April 2021, 6 days after the date of the ONS antibody snapshot, 64% of the population had received at least one dose of vaccine, 10 percentage points higher than the 54% rate of antibodies.

Studies provide insights into characteristics and clinical effect of SARS-CoV-2 B 1 1 7 variant

Studies provide insights into characteristics and clinical effect of SARS-CoV-2 B.1.1.7 variant Two new studies, published in The Lancet Infectious Diseases and The Lancet Public Health, found no evidence that people with the B.1.1.7. variant experience worse symptoms or a heightened risk of developing long COVID compared with those infected with a different COVID-19 strain. However, viral load and R number were higher for B.1.1.7., adding to growing evidence that it is more transmissible than the first strain detected in Wuhan, China, in December 2019. The emergence of variants has raised concerns that they could spread more easily and be more deadly, and that vaccines developed based on the original strain might be less effective against them. Preliminary data on B.1.1.7. indicates that it is more transmissible, with some evidence suggesting it could also be associated with increased hospitalisations and deaths. However, because the variant was identified only recently, these

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.